Circulation:PI3Kβ调节周细胞成熟以控制血管重塑

2020-08-25 MedSci原创 MedSci原创

周细胞(pericyte)是一种包围全身毛细血管和静脉中的内皮细胞的细胞,其嵌入毛细血管内皮细胞的基膜中,通过物理接触和旁分泌信号与内皮细胞进行细胞通讯,监视和稳定内皮细胞的成熟过程。

周细胞(pericyte)又称Rouget细胞和壁细胞,是一种包围全身毛细血管和静脉中的内皮细胞的细胞,其嵌入毛细血管内皮细胞的基膜中,通过物理接触和旁分泌信号与内皮细胞进行细胞通讯,监视和稳定内皮细胞的成熟过程。周细胞缺失与糖尿病性视网膜病、癌症等多种疾病相关。但目前对其在血管生成过程中的功能及分子调控尚未完全明确。

为了阐明周细胞在血管生成过程中的转录组程序,研究人员将Pdgfrb(BAC)-CreERT2小鼠与RiboTagflox/flox小鼠杂交,以评估周细胞的形态变化。

在血管生成开始时,周细胞表现出细胞增殖和激活的PI3K信号传导的分子特征,但在血管重塑期间,参与成熟周细胞功能的基因上调,而且PI3K信号明显减弱。未成熟的周细胞为星状形状,表现为高度增殖,而成熟的周细胞则为静止且伸长的形态。出乎意料的是,研究人员发现是PI3Kβ,而不是PI3Kα,在血管形成过程中调节周细胞的增殖和成熟。遗传性PI3Kβ失活触发了周细胞的早期成熟。相反,通过PTEN缺失释放PI3K信号可延迟周细胞的成熟。在血管生成过程中,周细胞成熟对血管重塑必不可少。

该研究结果揭示了一种新的与周细胞成熟相关分子形态特征,强调了PI3Kβ活性是确保血管正常生成的检查点。该研究或许为开辟以PI3Kβ活性为靶点的治疗病理性血管生成的新疗法提供了思路。

原始出处:

Ana M. Figueiredo,et al. Phosphoinositide 3-Kinase–Regulated Pericyte Maturation Governs Vascular Remodeling. Circulation. 2020;142:688–704

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1748084, encodeId=7c1d1e48084f9, content=<a href='/topic/show?id=e35439588ea' target=_blank style='color:#2F92EE;'>#周细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39588, encryptionId=e35439588ea, topicName=周细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17fd36043248, createdName=mhm301, createdTime=Mon Dec 14 05:03:43 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894383, encodeId=6d138943833d, content=谢谢,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJHmctib8wsjB1Y0etxU20nsCbR8rZ2fpibp2STmwH2YzicIsTe9oHRGB6XIMeBqNdIvxODicmzfeQibIw/132, createdBy=82211964557, createdName=清幽蓝燕yan, createdTime=Sun Oct 25 20:05:33 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632991, encodeId=7501163299179, content=<a href='/topic/show?id=785389e9570' target=_blank style='color:#2F92EE;'>#血管重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89795, encryptionId=785389e9570, topicName=血管重塑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=925121977560, createdName=xre2015, createdTime=Tue Oct 20 05:03:43 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813227, encodeId=6b4c81322e1f, content=haode, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uUDZhoIJG7kgBjjibEZxg3jwx0iaIiacwRte84CUNmbicKzGoOBnZDdHX4E1W2We8jUTrsqgUibAic3MM1c90Ie5iay7w/132, createdBy=c41c5308103, createdName=lifahui, createdTime=Tue Aug 25 22:18:52 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814133, encodeId=857d814133e3, content=号文件, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:10 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814132, encodeId=4d88814132d4, content=好分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:01 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813918, encodeId=f492813918f3, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:06:06 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333236, encodeId=16a2133323675, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14231, encryptionId=ecfa1423117, topicName=PI3K)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/BF4BC9769C2FF12AC93CAA0069C0696C/100, createdBy=7bb22500091, createdName=ms1292405679162969, createdTime=Thu Aug 27 08:03:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813643, encodeId=b8ca813643ca, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 07:09:41 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813354, encodeId=0c6881335477, content=很详细,很有用,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Wed Aug 26 09:17:16 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
    2020-12-14 mhm301
  2. [GetPortalCommentsPageByObjectIdResponse(id=1748084, encodeId=7c1d1e48084f9, content=<a href='/topic/show?id=e35439588ea' target=_blank style='color:#2F92EE;'>#周细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39588, encryptionId=e35439588ea, topicName=周细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17fd36043248, createdName=mhm301, createdTime=Mon Dec 14 05:03:43 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894383, encodeId=6d138943833d, content=谢谢,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJHmctib8wsjB1Y0etxU20nsCbR8rZ2fpibp2STmwH2YzicIsTe9oHRGB6XIMeBqNdIvxODicmzfeQibIw/132, createdBy=82211964557, createdName=清幽蓝燕yan, createdTime=Sun Oct 25 20:05:33 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632991, encodeId=7501163299179, content=<a href='/topic/show?id=785389e9570' target=_blank style='color:#2F92EE;'>#血管重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89795, encryptionId=785389e9570, topicName=血管重塑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=925121977560, createdName=xre2015, createdTime=Tue Oct 20 05:03:43 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813227, encodeId=6b4c81322e1f, content=haode, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uUDZhoIJG7kgBjjibEZxg3jwx0iaIiacwRte84CUNmbicKzGoOBnZDdHX4E1W2We8jUTrsqgUibAic3MM1c90Ie5iay7w/132, createdBy=c41c5308103, createdName=lifahui, createdTime=Tue Aug 25 22:18:52 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814133, encodeId=857d814133e3, content=号文件, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:10 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814132, encodeId=4d88814132d4, content=好分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:01 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813918, encodeId=f492813918f3, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:06:06 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333236, encodeId=16a2133323675, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14231, encryptionId=ecfa1423117, topicName=PI3K)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/BF4BC9769C2FF12AC93CAA0069C0696C/100, createdBy=7bb22500091, createdName=ms1292405679162969, createdTime=Thu Aug 27 08:03:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813643, encodeId=b8ca813643ca, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 07:09:41 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813354, encodeId=0c6881335477, content=很详细,很有用,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Wed Aug 26 09:17:16 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
    2020-10-25 清幽蓝燕yan

    谢谢,好文章

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1748084, encodeId=7c1d1e48084f9, content=<a href='/topic/show?id=e35439588ea' target=_blank style='color:#2F92EE;'>#周细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39588, encryptionId=e35439588ea, topicName=周细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17fd36043248, createdName=mhm301, createdTime=Mon Dec 14 05:03:43 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894383, encodeId=6d138943833d, content=谢谢,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJHmctib8wsjB1Y0etxU20nsCbR8rZ2fpibp2STmwH2YzicIsTe9oHRGB6XIMeBqNdIvxODicmzfeQibIw/132, createdBy=82211964557, createdName=清幽蓝燕yan, createdTime=Sun Oct 25 20:05:33 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632991, encodeId=7501163299179, content=<a href='/topic/show?id=785389e9570' target=_blank style='color:#2F92EE;'>#血管重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89795, encryptionId=785389e9570, topicName=血管重塑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=925121977560, createdName=xre2015, createdTime=Tue Oct 20 05:03:43 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813227, encodeId=6b4c81322e1f, content=haode, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uUDZhoIJG7kgBjjibEZxg3jwx0iaIiacwRte84CUNmbicKzGoOBnZDdHX4E1W2We8jUTrsqgUibAic3MM1c90Ie5iay7w/132, createdBy=c41c5308103, createdName=lifahui, createdTime=Tue Aug 25 22:18:52 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814133, encodeId=857d814133e3, content=号文件, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:10 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814132, encodeId=4d88814132d4, content=好分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:01 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813918, encodeId=f492813918f3, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:06:06 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333236, encodeId=16a2133323675, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14231, encryptionId=ecfa1423117, topicName=PI3K)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/BF4BC9769C2FF12AC93CAA0069C0696C/100, createdBy=7bb22500091, createdName=ms1292405679162969, createdTime=Thu Aug 27 08:03:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813643, encodeId=b8ca813643ca, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 07:09:41 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813354, encodeId=0c6881335477, content=很详细,很有用,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Wed Aug 26 09:17:16 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1748084, encodeId=7c1d1e48084f9, content=<a href='/topic/show?id=e35439588ea' target=_blank style='color:#2F92EE;'>#周细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39588, encryptionId=e35439588ea, topicName=周细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17fd36043248, createdName=mhm301, createdTime=Mon Dec 14 05:03:43 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894383, encodeId=6d138943833d, content=谢谢,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJHmctib8wsjB1Y0etxU20nsCbR8rZ2fpibp2STmwH2YzicIsTe9oHRGB6XIMeBqNdIvxODicmzfeQibIw/132, createdBy=82211964557, createdName=清幽蓝燕yan, createdTime=Sun Oct 25 20:05:33 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632991, encodeId=7501163299179, content=<a href='/topic/show?id=785389e9570' target=_blank style='color:#2F92EE;'>#血管重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89795, encryptionId=785389e9570, topicName=血管重塑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=925121977560, createdName=xre2015, createdTime=Tue Oct 20 05:03:43 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813227, encodeId=6b4c81322e1f, content=haode, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uUDZhoIJG7kgBjjibEZxg3jwx0iaIiacwRte84CUNmbicKzGoOBnZDdHX4E1W2We8jUTrsqgUibAic3MM1c90Ie5iay7w/132, createdBy=c41c5308103, createdName=lifahui, createdTime=Tue Aug 25 22:18:52 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814133, encodeId=857d814133e3, content=号文件, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:10 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814132, encodeId=4d88814132d4, content=好分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:01 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813918, encodeId=f492813918f3, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:06:06 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333236, encodeId=16a2133323675, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14231, encryptionId=ecfa1423117, topicName=PI3K)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/BF4BC9769C2FF12AC93CAA0069C0696C/100, createdBy=7bb22500091, createdName=ms1292405679162969, createdTime=Thu Aug 27 08:03:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813643, encodeId=b8ca813643ca, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 07:09:41 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813354, encodeId=0c6881335477, content=很详细,很有用,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Wed Aug 26 09:17:16 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
    2020-08-25 lifahui

    haode

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1748084, encodeId=7c1d1e48084f9, content=<a href='/topic/show?id=e35439588ea' target=_blank style='color:#2F92EE;'>#周细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39588, encryptionId=e35439588ea, topicName=周细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17fd36043248, createdName=mhm301, createdTime=Mon Dec 14 05:03:43 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894383, encodeId=6d138943833d, content=谢谢,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJHmctib8wsjB1Y0etxU20nsCbR8rZ2fpibp2STmwH2YzicIsTe9oHRGB6XIMeBqNdIvxODicmzfeQibIw/132, createdBy=82211964557, createdName=清幽蓝燕yan, createdTime=Sun Oct 25 20:05:33 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632991, encodeId=7501163299179, content=<a href='/topic/show?id=785389e9570' target=_blank style='color:#2F92EE;'>#血管重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89795, encryptionId=785389e9570, topicName=血管重塑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=925121977560, createdName=xre2015, createdTime=Tue Oct 20 05:03:43 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813227, encodeId=6b4c81322e1f, content=haode, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uUDZhoIJG7kgBjjibEZxg3jwx0iaIiacwRte84CUNmbicKzGoOBnZDdHX4E1W2We8jUTrsqgUibAic3MM1c90Ie5iay7w/132, createdBy=c41c5308103, createdName=lifahui, createdTime=Tue Aug 25 22:18:52 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814133, encodeId=857d814133e3, content=号文件, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:10 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814132, encodeId=4d88814132d4, content=好分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:01 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813918, encodeId=f492813918f3, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:06:06 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333236, encodeId=16a2133323675, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14231, encryptionId=ecfa1423117, topicName=PI3K)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/BF4BC9769C2FF12AC93CAA0069C0696C/100, createdBy=7bb22500091, createdName=ms1292405679162969, createdTime=Thu Aug 27 08:03:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813643, encodeId=b8ca813643ca, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 07:09:41 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813354, encodeId=0c6881335477, content=很详细,很有用,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Wed Aug 26 09:17:16 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
    2020-08-27 ms4000002082197205

    号文件

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1748084, encodeId=7c1d1e48084f9, content=<a href='/topic/show?id=e35439588ea' target=_blank style='color:#2F92EE;'>#周细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39588, encryptionId=e35439588ea, topicName=周细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17fd36043248, createdName=mhm301, createdTime=Mon Dec 14 05:03:43 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894383, encodeId=6d138943833d, content=谢谢,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJHmctib8wsjB1Y0etxU20nsCbR8rZ2fpibp2STmwH2YzicIsTe9oHRGB6XIMeBqNdIvxODicmzfeQibIw/132, createdBy=82211964557, createdName=清幽蓝燕yan, createdTime=Sun Oct 25 20:05:33 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632991, encodeId=7501163299179, content=<a href='/topic/show?id=785389e9570' target=_blank style='color:#2F92EE;'>#血管重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89795, encryptionId=785389e9570, topicName=血管重塑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=925121977560, createdName=xre2015, createdTime=Tue Oct 20 05:03:43 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813227, encodeId=6b4c81322e1f, content=haode, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uUDZhoIJG7kgBjjibEZxg3jwx0iaIiacwRte84CUNmbicKzGoOBnZDdHX4E1W2We8jUTrsqgUibAic3MM1c90Ie5iay7w/132, createdBy=c41c5308103, createdName=lifahui, createdTime=Tue Aug 25 22:18:52 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814133, encodeId=857d814133e3, content=号文件, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:10 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814132, encodeId=4d88814132d4, content=好分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:01 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813918, encodeId=f492813918f3, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:06:06 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333236, encodeId=16a2133323675, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14231, encryptionId=ecfa1423117, topicName=PI3K)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/BF4BC9769C2FF12AC93CAA0069C0696C/100, createdBy=7bb22500091, createdName=ms1292405679162969, createdTime=Thu Aug 27 08:03:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813643, encodeId=b8ca813643ca, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 07:09:41 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813354, encodeId=0c6881335477, content=很详细,很有用,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Wed Aug 26 09:17:16 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
    2020-08-27 ms4000002082197205

    好分享

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1748084, encodeId=7c1d1e48084f9, content=<a href='/topic/show?id=e35439588ea' target=_blank style='color:#2F92EE;'>#周细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39588, encryptionId=e35439588ea, topicName=周细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17fd36043248, createdName=mhm301, createdTime=Mon Dec 14 05:03:43 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894383, encodeId=6d138943833d, content=谢谢,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJHmctib8wsjB1Y0etxU20nsCbR8rZ2fpibp2STmwH2YzicIsTe9oHRGB6XIMeBqNdIvxODicmzfeQibIw/132, createdBy=82211964557, createdName=清幽蓝燕yan, createdTime=Sun Oct 25 20:05:33 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632991, encodeId=7501163299179, content=<a href='/topic/show?id=785389e9570' target=_blank style='color:#2F92EE;'>#血管重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89795, encryptionId=785389e9570, topicName=血管重塑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=925121977560, createdName=xre2015, createdTime=Tue Oct 20 05:03:43 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813227, encodeId=6b4c81322e1f, content=haode, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uUDZhoIJG7kgBjjibEZxg3jwx0iaIiacwRte84CUNmbicKzGoOBnZDdHX4E1W2We8jUTrsqgUibAic3MM1c90Ie5iay7w/132, createdBy=c41c5308103, createdName=lifahui, createdTime=Tue Aug 25 22:18:52 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814133, encodeId=857d814133e3, content=号文件, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:10 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814132, encodeId=4d88814132d4, content=好分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:01 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813918, encodeId=f492813918f3, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:06:06 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333236, encodeId=16a2133323675, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14231, encryptionId=ecfa1423117, topicName=PI3K)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/BF4BC9769C2FF12AC93CAA0069C0696C/100, createdBy=7bb22500091, createdName=ms1292405679162969, createdTime=Thu Aug 27 08:03:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813643, encodeId=b8ca813643ca, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 07:09:41 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813354, encodeId=0c6881335477, content=很详细,很有用,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Wed Aug 26 09:17:16 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
    2020-08-27 ms7000000689223974

    很好很详细,谢谢分享

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1748084, encodeId=7c1d1e48084f9, content=<a href='/topic/show?id=e35439588ea' target=_blank style='color:#2F92EE;'>#周细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39588, encryptionId=e35439588ea, topicName=周细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17fd36043248, createdName=mhm301, createdTime=Mon Dec 14 05:03:43 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894383, encodeId=6d138943833d, content=谢谢,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJHmctib8wsjB1Y0etxU20nsCbR8rZ2fpibp2STmwH2YzicIsTe9oHRGB6XIMeBqNdIvxODicmzfeQibIw/132, createdBy=82211964557, createdName=清幽蓝燕yan, createdTime=Sun Oct 25 20:05:33 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632991, encodeId=7501163299179, content=<a href='/topic/show?id=785389e9570' target=_blank style='color:#2F92EE;'>#血管重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89795, encryptionId=785389e9570, topicName=血管重塑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=925121977560, createdName=xre2015, createdTime=Tue Oct 20 05:03:43 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813227, encodeId=6b4c81322e1f, content=haode, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uUDZhoIJG7kgBjjibEZxg3jwx0iaIiacwRte84CUNmbicKzGoOBnZDdHX4E1W2We8jUTrsqgUibAic3MM1c90Ie5iay7w/132, createdBy=c41c5308103, createdName=lifahui, createdTime=Tue Aug 25 22:18:52 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814133, encodeId=857d814133e3, content=号文件, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:10 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814132, encodeId=4d88814132d4, content=好分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:01 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813918, encodeId=f492813918f3, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:06:06 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333236, encodeId=16a2133323675, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14231, encryptionId=ecfa1423117, topicName=PI3K)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/BF4BC9769C2FF12AC93CAA0069C0696C/100, createdBy=7bb22500091, createdName=ms1292405679162969, createdTime=Thu Aug 27 08:03:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813643, encodeId=b8ca813643ca, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 07:09:41 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813354, encodeId=0c6881335477, content=很详细,很有用,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Wed Aug 26 09:17:16 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=1748084, encodeId=7c1d1e48084f9, content=<a href='/topic/show?id=e35439588ea' target=_blank style='color:#2F92EE;'>#周细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39588, encryptionId=e35439588ea, topicName=周细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17fd36043248, createdName=mhm301, createdTime=Mon Dec 14 05:03:43 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894383, encodeId=6d138943833d, content=谢谢,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJHmctib8wsjB1Y0etxU20nsCbR8rZ2fpibp2STmwH2YzicIsTe9oHRGB6XIMeBqNdIvxODicmzfeQibIw/132, createdBy=82211964557, createdName=清幽蓝燕yan, createdTime=Sun Oct 25 20:05:33 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632991, encodeId=7501163299179, content=<a href='/topic/show?id=785389e9570' target=_blank style='color:#2F92EE;'>#血管重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89795, encryptionId=785389e9570, topicName=血管重塑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=925121977560, createdName=xre2015, createdTime=Tue Oct 20 05:03:43 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813227, encodeId=6b4c81322e1f, content=haode, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uUDZhoIJG7kgBjjibEZxg3jwx0iaIiacwRte84CUNmbicKzGoOBnZDdHX4E1W2We8jUTrsqgUibAic3MM1c90Ie5iay7w/132, createdBy=c41c5308103, createdName=lifahui, createdTime=Tue Aug 25 22:18:52 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814133, encodeId=857d814133e3, content=号文件, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:10 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814132, encodeId=4d88814132d4, content=好分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:01 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813918, encodeId=f492813918f3, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:06:06 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333236, encodeId=16a2133323675, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14231, encryptionId=ecfa1423117, topicName=PI3K)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/BF4BC9769C2FF12AC93CAA0069C0696C/100, createdBy=7bb22500091, createdName=ms1292405679162969, createdTime=Thu Aug 27 08:03:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813643, encodeId=b8ca813643ca, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 07:09:41 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813354, encodeId=0c6881335477, content=很详细,很有用,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Wed Aug 26 09:17:16 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
    2020-08-27 14818eb4m67暂无昵称

    学习了

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1748084, encodeId=7c1d1e48084f9, content=<a href='/topic/show?id=e35439588ea' target=_blank style='color:#2F92EE;'>#周细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39588, encryptionId=e35439588ea, topicName=周细胞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17fd36043248, createdName=mhm301, createdTime=Mon Dec 14 05:03:43 CST 2020, time=2020-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=894383, encodeId=6d138943833d, content=谢谢,好文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJHmctib8wsjB1Y0etxU20nsCbR8rZ2fpibp2STmwH2YzicIsTe9oHRGB6XIMeBqNdIvxODicmzfeQibIw/132, createdBy=82211964557, createdName=清幽蓝燕yan, createdTime=Sun Oct 25 20:05:33 CST 2020, time=2020-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1632991, encodeId=7501163299179, content=<a href='/topic/show?id=785389e9570' target=_blank style='color:#2F92EE;'>#血管重塑#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89795, encryptionId=785389e9570, topicName=血管重塑)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=925121977560, createdName=xre2015, createdTime=Tue Oct 20 05:03:43 CST 2020, time=2020-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813227, encodeId=6b4c81322e1f, content=haode, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/uUDZhoIJG7kgBjjibEZxg3jwx0iaIiacwRte84CUNmbicKzGoOBnZDdHX4E1W2We8jUTrsqgUibAic3MM1c90Ie5iay7w/132, createdBy=c41c5308103, createdName=lifahui, createdTime=Tue Aug 25 22:18:52 CST 2020, time=2020-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814133, encodeId=857d814133e3, content=号文件, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:10 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814132, encodeId=4d88814132d4, content=好分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ce05381686, createdName=ms4000002082197205, createdTime=Thu Aug 27 17:38:01 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813918, encodeId=f492813918f3, content=很好很详细,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Thu Aug 27 10:06:06 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1333236, encodeId=16a2133323675, content=<a href='/topic/show?id=ecfa1423117' target=_blank style='color:#2F92EE;'>#PI3K#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14231, encryptionId=ecfa1423117, topicName=PI3K)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/BF4BC9769C2FF12AC93CAA0069C0696C/100, createdBy=7bb22500091, createdName=ms1292405679162969, createdTime=Thu Aug 27 08:03:43 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813643, encodeId=b8ca813643ca, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 07:09:41 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813354, encodeId=0c6881335477, content=很详细,很有用,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200823/ece0a24ea5824924b9ba0b87a5947f86/11f20d29045c49fd9671ef69fa0c4012.jpg, createdBy=f64a5412720, createdName=ms7000000689223974, createdTime=Wed Aug 26 09:17:16 CST 2020, time=2020-08-26, status=1, ipAttribution=)]
    2020-08-26 ms7000000689223974

    很详细,很有用,谢谢分享

    0

相关资讯

CLIN CANCER RES:PI3K和CDK4/6联合抑制治疗PIK3CA突变肺鳞状细胞癌

肺鳞状细胞癌(LUSC)是非小细胞肺癌的主要亚型,其特征是存在多种遗传改变,特别PI3K通路改变,在超过50%的LUSC病例中得到证实。尽管是具有治疗前景的靶点,单一药物PI3K抑制剂在LUSC中表现的治疗效果一般。因此需要靶向LUSC的新型组合疗法。CLIN CANCER RES近期发表了一篇文章研究这一问题。

2019年ASCO:Umbralisib单药治疗边缘区淋巴瘤的阳性中期数据(UNITY-NHL试验)

TG制药公司近日公布了IIb期UNITY-NHL试验的中期数据,UNITY-NHL试验正在评估Umbralisib作为复发/难治边缘区淋巴瘤(MZL)患者的单药疗法的有效性和安全性。

Exp Eye Res:MicroRNA-218-5p通过PI3K / Akt / mTOR信号通路靶向EGFR抑制翼状胬肉上皮细胞的迁移和增殖

天津市眼科医院的Han S等人近日在Exp Eye Res杂志上发表了一项重要工作。翼状胬肉是一种常见的眼表疾病,可引起各种眼表症状。微RNA在各种眼部疾病的发展中起重要作用。然而,对于microRNA在翼状胬肉中的发病机制中的作用很少研究。他们的研究旨在分析人的翼状胬肉组织和培养的人翼状胬肉上皮细胞(hPECs)中miR-218-5p与表皮生长因子受体(EGFR)之间的关系。另外,他们还首次发现

Science Signal:Rac1不依赖PI3K和GTPase介导MET驱动的锚定非依赖性细胞生长

锚定非依赖性增殖和细胞迁移对肿瘤生长和转移扩散均至关重要。这些行为都是由生长因子受体信号驱动,一般是激酶PI3K及其下游效应器。但近期研究人员发现,在培养的细胞和移植瘤小鼠中,并非如此……

王晓稼教授:探路前方,且看mTORi和PI3Ki如何逆转内分泌耐药

2019ASCO大会上,MONALEESA-7研究历史性地展示了Ribociclib一线治疗晚期HR阳性乳腺癌的OS获益,CDK4/6抑制剂延缓内分泌耐药进程再获里程碑式的阳性结果。欣喜之余,专家们的目光也开始延伸到内分泌耐药乃至CDK4/6抑制剂进展后的治疗选择。SOLAR-1和BYLieve研究中PI3K抑制剂Alpelisib的积极探索,向世人展示了另一条通向逆转内分泌耐药的康庄大路。

Blood:核内FOXO1可促进生发中心B细胞衍生的淋巴瘤进展

中心点:在Burtitt(伯基特)淋巴瘤中,FOXO1为复发性突变。在伯基特淋巴瘤中,核FOXO1可促进细胞增殖和存活。摘要:FOXO1在固体肿瘤中发挥肿瘤抑制因子的作用。致瘤性PI3K信号通路通过AKT介导的磷酸化增强其核排斥来抑制FOXO1的转录活性。Eleni Kabrani等人发现在伯基特淋巴瘤(BL)中,FOXO1在核内高表达,BL是一种来源于生发中心(GC)B细胞的淋巴瘤,其病理机制与